The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 10, 2022
Filed:
May. 25, 2021
Applicant:
Union Therapeutics A/s, Hellerup, DK;
Inventors:
Morten Otto Alexander Sommer, Hellerup, DK;
Rasmus Toft-Kehler, Hellerup, DK;
Anne Katrine Toft-Kehler, Hellerup, DK;
Günter Ditzinger, Hellerup, DK;
Mads Jellingsoe, Hellerup, DK;
Philippe Andres, Hellerup, DK;
Matthias Manne Knopp, Hellerup, DK;
Assignee:
UNION therapeutics A/S, Hellerup, DK;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/167 (2006.01); A61K 9/08 (2006.01); A61K 9/10 (2006.01); A61K 47/32 (2006.01); A61K 47/40 (2006.01); A61K 9/00 (2006.01); A61K 9/12 (2006.01);
U.S. Cl.
CPC ...
A61K 31/167 (2013.01); A61K 9/0043 (2013.01); A61K 9/0073 (2013.01); A61K 9/08 (2013.01); A61K 9/12 (2013.01); A61K 47/32 (2013.01); A61K 47/40 (2013.01);
Abstract
The invention relates to a method of treating a viral infection caused by or associated with SARS-CoV-2 in a subject, the method comprising administering to the subject by inhalation intraorally and/or intranasally a therapeutically effective amount of a formulation comprising niclosamide, or a pharmaceutically acceptable salt thereof, and a cyclodextrin.